Negative regulation of nodal signaling pathway

pathway activity — cross-omics
GO:1900108Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of nodal signaling pathway pathway is significantly associated with the protein abundance of multiple proteins, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ERGIC2, SND1, and PDIA4, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of nodal signaling pathway activity versus ERGIC2 in CCRCC (Pearson r = 0.29).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCERGIC2 →+0.447+0.148<.001<.00135
CCRCCSND1 →+0.137+0.082<.001<.00135
CCRCCPDIA4 →+0.386+0.121<.001<.00135
CCRCCALDH18A1 →+0.415+0.085<.001<.00134
BRCATMED2 →+0.383+0.066<.001.00234
BRCACD63 →+0.526+0.073.006<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1900108 vs ERGIC2 — CCRCC

Per-sample scatter of Negative regulation of nodal signaling pathway activity vs ERGIC2 in CCRCC.

Explore this scatter interactively →

Exploration